The 'New' Vifor Pharma: Focused On Specialty Pharma

 
• By John Davis

With a new hyperkalemia therapy nearing EU markets and its injectable iron product showing strong sales growth, Switzerland’s global specialty pharma company Vifor Pharma has been able to upgrade its financial guidance for 2017.

Etienne Jornod
Etienne Jornod, executive chairman of Vifor Pharma • Source: Vifor Pharma

More from Strategy

More from Business